Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pneumococcal 13-valent Conjugate Vaccine”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02943902
What this trial is testing

Reduced PCV Dosing Schedules in South African Infants

Who this might be right for
PneumoniaMeningitis
University of Witwatersrand, South Africa 600
Large-scale testing (Phase 3)Study completedNCT00368966
What this trial is testing

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

Who this might be right for
Vaccines, Pneumococcal
Wyeth is now a wholly owned subsidiary of Pfizer 619
Not applicableWithdrawnNCT02357823
What this trial is testing

Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults

Who this might be right for
HIVPneumococcal Infections
University of Siena
Not applicableStudy completedNCT01272999
What this trial is testing

Impact of Prevnar 13 on Ear Infections in Children

Who this might be right for
Acute Otitis MediaMastoiditis
Pfizer 391
Large-scale testing (Phase 3)Study completedNCT00743652
What this trial is testing

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Who this might be right for
Pneumococcal Disease13-valent Pneumococcal Vaccine
Pfizer 373
Not applicableUnknownNCT04551248
What this trial is testing

Post-marketing Safety Evaluation of Pneumococcal Vaccines Among Children and Elderly Adults.

Who this might be right for
Pneumococcal Vaccine Adverse Reaction
Sungkyunkwan University 1,000,000
Large-scale testing (Phase 3)UnknownNCT05934890
What this trial is testing

Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13

Who this might be right for
Pneumococcal Disease, Invasive
Walvax Biotechnology Co., Ltd. 630
Large-scale testing (Phase 3)Not Yet RecruitingNCT07593924
What this trial is testing

Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)

Who this might be right for
Pneumococcal Infectious Diseases
Sinovac Life Sciences Co., Ltd. 500
Large-scale testing (Phase 3)Looking for participantsNCT06617715
What this trial is testing

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

Who this might be right for
Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd. 3,080
Post-approval studies (Phase 4)Study completedNCT01781871
What this trial is testing

Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients

Who this might be right for
Kidney TransplantationLiver Transplantation
Helsinki University Central Hospital 182
Large-scale testing (Phase 3)Study completedNCT00918580
What this trial is testing

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease

Who this might be right for
Pneumococcal Conjugate Vaccine
Pfizer 158
Large-scale testing (Phase 3)Looking for participantsNCT06608199
What this trial is testing

Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Who this might be right for
Pneumococcal VaccinesPneumococcal Infections
Beijing Minhai Biotechnology Co., Ltd 500
Not applicableStudy completedNCT01425372
What this trial is testing

Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months

Who this might be right for
Streptococcus Pneumoniae
Prof. Elizabeth Miller 93
Not applicableStudy completedNCT01128426
What this trial is testing

Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

Who this might be right for
Pneumococcal Disease
Pfizer 53,902
Large-scale testing (Phase 3)Study completedNCT00963235
What this trial is testing

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

Who this might be right for
HIV InfectionsPneumococcal Infections
Pfizer 331
Large-scale testing (Phase 3)Study completedNCT03621670
What this trial is testing

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,196
Large-scale testing (Phase 3)Study completedNCT01964716
What this trial is testing

13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.

Who this might be right for
Pneumococcal Vaccines
Pfizer 500
Post-approval studies (Phase 4)Study completedNCT03548337
What this trial is testing

Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India

Who this might be right for
Vaccines
Pfizer 301
Early research (Phase 1)Study completedNCT01531322
What this trial is testing

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects

Who this might be right for
Pneumococcal Infection
Pfizer 72
Large-scale testing (Phase 3)Study completedNCT01953510
What this trial is testing

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam

Who this might be right for
Pneumococcal Vaccines
Murdoch Childrens Research Institute 1,400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation